Holen Sie sich die Stockscreener-App
15.82
4.08%
0.62
Kalvista Pharmaceuticals Inc Aktie (KALV) Neueste Nachrichten
Short interest data insights for KalVista Pharmaceuticals Inc.2025 Top Gainers & Daily Volume Surge Signals - Newser
Is KalVista Pharmaceuticals Inc. stock a smart retirement pickWeekly Stock Recap & Reliable Volume Spike Alerts - خودرو بانک
Aug Rallies: What is KalVista Pharmaceuticals Inc. s 5 year growth outlook2025 Big Picture & Capital Protection Trade Alerts - خودرو بانک
What analysts say about KalVista Pharmaceuticals Inc. stock2025 Risk Factors & Breakout Confirmation Trade Signals - خودرو بانک
Can KalVista Pharmaceuticals Inc. deliver consistent dividendsQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - خودرو بانک
Can technical indicators confirm KalVista Pharmaceuticals Inc.’s reversalChart Signals & Safe Entry Point Alerts - Newser
KalVista Pharmaceuticals Inc. stock volume spike explainedGap Down & Real-Time Stock Entry Alerts - Newser
Does KalVista Pharmaceuticals (NASDAQ:KALV) Have A Healthy Balance Sheet? - 富途牛牛
Is KalVista Pharmaceuticals Inc. building a consolidation base2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
What MACD and RSI say about KalVista Pharmaceuticals Inc.Analyst Downgrade & High Conviction Buy Zone Alerts - Newser
Is KalVista Pharmaceuticals (NASDAQ:KALV) A Risky Investment? - simplywall.st
Can volume confirm reversal in KalVista Pharmaceuticals Inc.2025 Market Trends & Low Drawdown Trading Techniques - Newser
Combining machine learning predictions for KalVista Pharmaceuticals Inc.Trend Reversal & Daily Volume Surge Signals - Newser
Evaluating KalVista Pharmaceuticals Inc. with trendline analysisMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Can KalVista Pharmaceuticals Inc. maintain sales growthEarnings Growth Summary & Stepwise Entry and Exit Trade Signals - خودرو بانک
KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025 - Business Wire
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
KalVista Q1 Earnings On DeckWill Sebetralstat's EU Nod Be The Catalyst It Needs? - RTTNews
Institutional scanner results for KalVista Pharmaceuticals Inc.Wall Street Watch & High Accuracy Swing Entry Alerts - Newser
Applying Elliott Wave Theory to KalVista Pharmaceuticals Inc.Weekly Trade Review & Daily Chart Pattern Signal Reports - Newser
What’s the recovery path for long term holders of KalVista Pharmaceuticals Inc.2025 Volatility Report & Free Weekly Watchlist of Top Performers - Newser
What is KalVista Pharmaceuticals Inc. s debt to equity ratioDip Buying & Safe Entry Point Identification - خودرو بانک
Price action breakdown for KalVista Pharmaceuticals Inc.Jobs Report & Verified Momentum Stock Ideas - Newser
How high can KalVista Pharmaceuticals Inc. stock goMarket Growth Review & Weekly Watchlist for Hot Stocks - Newser
Price momentum metrics for KalVista Pharmaceuticals Inc. explainedSwing Trade & Weekly Top Performers Watchlists - Newser
Chart based exit strategy for KalVista Pharmaceuticals Inc.2025 Top Decliners & AI Driven Stock Reports - Newser
How institutional ownership impacts KalVista Pharmaceuticals Inc. stock2025 Top Gainers & Consistent Profit Alerts - Newser
KALVISTA PHARMACEUTICALS Earnings Preview: Recent $KALV Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
KalVista Pharmaceuticals Inc. Recovers — But Is It Sustainable getLinesFromResByArray error: size == 0 - 강소기업뉴스
Analyzing recovery setups for KalVista Pharmaceuticals Inc. investorsTrade Volume Report & Technical Entry and Exit Tips - Newser
Real time social sentiment graph for AFRIWJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Sentiment analysis tools applied to KalVista Pharmaceuticals Inc.July 2025 Volume & Fast Gaining Stock Reports - Newser
Heatmap Data Shows High Activity in KalVista Pharmaceuticals Inc. Sector2025 Pullback Review & Growth Oriented Trading Recommendations - beatles.ru
How to build a dashboard for KalVista Pharmaceuticals Inc. stockWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):